ALLO · Allogene Therapeutics, Inc.

$2.05 +0.07 (+3.54%) At close · Aug 14

Market Cap

$708.26M

345.49M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-12	2026-06-30
8-K	2026-08-12	—
Investor Event Transcript	2026-06-30	—
8-K	2026-06-22	2026-06-18
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-05-28	—
10-Q	2026-05-13	2026-03-31
8-K	2026-05-13	2026-05-12
DEF 14A	2026-04-30	2026-06-18
8-K	2026-04-15	2026-04-14
8-K	2026-04-13	—
8-K	2026-04-13	—
8-K	2026-03-12	—
10-K	2026-03-12	2025-12-31
8-K	2025-11-06	—
10-Q	2025-11-06	2025-09-30
8-K	2025-10-14	2025-09-26
10-Q	2025-08-13	2025-06-30
8-K	2025-08-13	—
8-K	2025-08-01	—
8-K	2025-06-23	2025-06-18
8-K	2025-05-13	—
10-Q	2025-05-13	2025-03-31
DEF 14A	2025-04-30	2025-06-18
8-K	2025-03-13	—
10-K	2025-03-13	2024-12-31
8-K	2025-02-25	2025-02-19
8-K	2025-01-29	2025-01-23
8-K	2024-11-13	2024-11-11
10-Q	2024-11-07	2024-09-30
8-K	2024-11-07	—
8-K	2024-10-07	2024-10-03
10-Q	2024-08-07	2024-06-30
8-K	2024-08-07	—
8-K	2024-06-10	2024-06-05
8-K	2024-05-31	2024-05-24
8-K	2024-05-14	2024-05-13
10-Q	2024-05-13	2024-03-31
8-K	2024-05-13	—
DEF 14A	2024-04-23	2024-06-05
10-K	2024-03-14	2023-12-31
8-K	2024-03-14	—
10-K/A	2024-03-14	2022-12-31
8-K	2024-02-16	2024-02-14
8-K	2024-01-31	2024-01-25
8-K	2024-01-05	2024-01-03
8-K	2023-12-19	2023-12-09
8-K	2023-11-02	—
10-Q	2023-11-02	2023-09-30
8-K/A	2023-10-17	2023-10-16

Showing 1–50 of 110 filings

Key facts CIK 1737287 CUSIP 019770106 13F (30d) 203 filings 200 filers Visit website Investor relations